7301. Trends in Mortality Among Pregnant and Recently Pregnant Women in the US, 2015-2019.
作者: Jeffrey T Howard.;Corey S Sparks.;Alexis R Santos-Lozada.;Samson A Olowolaju.;Jud C Janak.;Krista J Howard.
来源: JAMA. 2021年326卷16期1631-1633页
This study uses National Center for Health Statistics data to assess mortality rates and their annual percentage changes for pregnancy-related and other causes among pregnant and recently pregnant women from 2015 to 2019, compared with cause-specific mortality rates in the total US female population of childbearing age.
7313. Effect of Platelet-Rich Plasma Injections vs Placebo on Ankle Symptoms and Function in Patients With Ankle Osteoarthritis: A Randomized Clinical Trial.
作者: Liam D A Paget.;Gustaaf Reurink.;Robert-Jan de Vos.;Adam Weir.;Maarten H Moen.;Sita M A Bierma-Zeinstra.;Sjoerd A S Stufkens.;Gino M M J Kerkhoffs.;Johannes L Tol.; .
来源: JAMA. 2021年326卷16期1595-1605页
Approximately 3.4% of adults have ankle (tibiotalar) osteoarthritis and, among younger patients, ankle osteoarthritis is more common than knee and hip osteoarthritis. Few effective nonsurgical interventions exist, but platelet-rich plasma (PRP) injections are widely used, with some evidence of efficacy in knee osteoarthritis.
7316. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement.
作者: Veronika W Skrivankova.;Rebecca C Richmond.;Benjamin A R Woolf.;James Yarmolinsky.;Neil M Davies.;Sonja A Swanson.;Tyler J VanderWeele.;Julian P T Higgins.;Nicholas J Timpson.;Niki Dimou.;Claudia Langenberg.;Robert M Golub.;Elizabeth W Loder.;Valentina Gallo.;Anne Tybjaerg-Hansen.;George Davey Smith.;Matthias Egger.;J Brent Richards.
来源: JAMA. 2021年326卷16期1614-1621页
Mendelian randomization (MR) studies use genetic variation associated with modifiable exposures to assess their possible causal relationship with outcomes and aim to reduce potential bias from confounding and reverse causation.
7319. USPSTF Approach to Addressing Sex and Gender When Making Recommendations for Clinical Preventive Services.
作者: Aaron B Caughey.;Alex H Krist.;Tracy A Wolff.;Michael J Barry.;Jillian T Henderson.;Douglas K Owens.;Karina W Davidson.;Melissa A Simon.;Carol M Mangione.
来源: JAMA. 2021年326卷19期1953-1961页
Clinical preventive service recommendations from the US Preventive Services Task Force (USPSTF) are based on transparent, systematic, and rigorous methods that consider the certainty of the evidence and magnitude of net benefit. These guidelines aim to address the needs of diverse populations. Biological sex and gender identity are sources of diversity that are not often considered in studies of clinical preventive services that inform the recommendations, resulting in challenges when evaluating the evidence and communicating recommendations for persons in specific gender identification categories (man/woman/gender nonbinary/gender nonconforming/transgender). To advance its methods, the USPSTF reviewed its past recommendations that included the use of sex and gender terms, reviewed the approaches of other guideline-making bodies, and pilot tested strategies to address sex and gender diversity. Based on the findings, the USPSTF intends to use an inclusive approach to identify issues related to sex and gender at the start of the guideline development process; assess the applicability, variability, and quality of evidence as a function of sex and gender; ensure clarity in the use of language regarding sex and gender; and identify evidence gaps related to sex and gender. Evidence reviews will identify the limitations of applying findings to diverse groups from underlying studies that used unclear terminology regarding sex and gender. The USPSTF will use gender-neutral language when appropriate to communicate that recommendations are inclusive of people of any gender and will clearly state when recommendations apply to individuals with specific anatomy associated with biological sex (male/female) or to specific categories of gender identity. The USPSTF recognizes limited evidence to inform the preventive care of populations based on gender identity.
7320. Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018.
作者: Srinivas Gaddam.;Yazan Abboud.;Janice Oh.;Jamil S Samaan.;Nicholas N Nissen.;Shelly C Lu.;Simon K Lo.
来源: JAMA. 2021年326卷20期2075-2077页
This study uses data from the Surveillance Epidemiology and End Results database to perform an age- and sex-specific time trend analysis of pancreatic cancer incidence rates in US adults.
|